Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB25FG61Q
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,083
Award facts
- Contract value 100% obligated
- $2,082.93 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $2,082.93 by the Defense Logistics Agency (DLA) on May 2, 2025, for the supply of Nexplanon 68 mg implants. The contract carries a firm fixed-price structure with no set-aside designation and is scheduled for completion by May 23, 2025. This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, which is valued at approximately $500 million and extends through November 2026, enabling the agency to procure a comprehensive range of pharmaceutical products supporting military healthcare facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier in the federal pharmaceutical supply chain, leveraging its woman-owned small business status to compete effectively in federal procurement markets. The company specializes in distributing branded and generic prescription drugs, biologics, over-the-counter medications, and medical consumables to Department of Defense healthcare sites. Under its master DLA contract, the company has secured delivery orders covering an extensive portfolio of pharmaceutical products ranging from contraceptive devices such as Nexplanon implants to oncology treatments, vaccines, and specialized medical supplies, demonstrating consistent capability to support the Defense Logistics Agency's pharmaceutical procurement requirements.
Quick answers
Who was awarded contract SPE2DB25FG61Q?
SPE2DB25FG61Q was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on May 2, 2025.
How much is contract SPE2DB25FG61Q worth?
The government has obligated $2,083 on SPE2DB25FG61Q.
Is contract SPE2DB25FG61Q an order under another contract?
Yes. SPE2DB25FG61Q is a delivery order under SPE2DB20D9157, an indefinite delivery contract.
Was contract SPE2DB25FG61Q competed?
The extent of competition for SPE2DB25FG61Q was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award